Cencora, Inc. · NYSE:COR

Cencora — AmerisourceBergen — Q2 FY2017 Earnings Presentation

14 slides from Cencora's earnings presentation, May 4, 2017

  1. Slide 1: Q2 FY2017 Financial Results

    Q2 FY2017 Financial Results May 4, 2017

  2. Slide 2: Cautionary Note Regarding Forward-Looking Statements

    Cautionary Note Regarding Forward-Looking Statements Certain of the statements contained in this presentation are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Words such as "expect," "likely," "ou

  3. Slide 3: AmerisourceBergen is creating healthier futures

    AmerisourceBergen is creating healthier futures • Shaping healthcare delivery through knowledge, reach and partnership • Providing industry leading services and solutions that improve product access, increase supply chain efficiency and enhance patient care 3

  4. Slide 4: Highly Differentiated & Strongly Positioned for Growth

    Highly Differentiated & Strongly Positioned for Growth Customer Base Innovative Services & • Key anchor customers Solutions • Fast growing • Customer-focused offerings serving • U.S. Pharmaceutical focus manufacturers and provider customers Leadership in Specialty Successful Financial Distribution &

  5. Slide 5: Q2 FY2017 Financial Results: Overview

    Q2 FY2017 Financial Results: Overview  Solid quarterly performance – AmerisourceBergen continues to demonstrate resilience and ability to execute in a challenging market - Continued leadership for ABSG: product volume and mix trends driving income growth - Excellent growth across businesses in Othe

  6. Slide 6: Q2 FY2017 Financial Results

    Q2 FY2017 Financial Results Adjusted GAAP (Non-GAAP)1 Revenue $37.1B $37.1B % Change (Year over Year) 4.1% 4.1% Gross Profit $1.3B $1.2B % Change 16.8% 0.2% Operating Expenses $631M $581M % Change 405.8% 1.4% Operating Income $625M $588M % Change (34.2%) (1.0%) Interest Expense, Net $37M $35M % Chan

  7. Slide 7: Pharmaceutical Distribution Services Segment

    Q2 FY2017 Financial Results: Pharmaceutical Distribution Services Segment Q2 FY2017 Q2 FY2016 Revenue $35.5B $34.2B Operating Income $482M $500M Percentages of Revenue Gross Profit 2.45% 2.58% Operating Expenses 1.09% 1.12% Operating Income 1.36% 1.46%  ABDC large anchor customers continue to grow

  8. Slide 8: Other Businesses – ABCS, MWI and World Courier

    Q2 FY2017 Financial Results: Other Businesses – ABCS, MWI and World Courier Q2 FY2017 Q2 FY2016 Revenue $1.7B $1.6B Operating Income $106M $94M Percentages of Revenue Gross Profit 17.75% 17.85% Operating Expenses 11.49% 11.97% Operating Income 6.26% 5.87%  Excellent income growth trends across all

  9. Slide 9: FY2017 Financial Guidance

    FY2017 Financial Guidance1 Expectations on an Adjusted (Non-GAAP) Basis Revenue Growth 5.5% to 6.5% Adjusted Diluted Earnings Per Share $5.77 to $5.92 Adjusted Operating Expense Growth 2% to 3% Adjusted Operating Income Flat to up 2% Adjusted Effective Tax Rate ~32% At or Slightly Above Free Cash Fl

  10. Slide 10: Appendix

    Appendix N) AmerisourceBergen:

  11. Slide 11: Appendix

    Appendix Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of the Company’s most recent Current Report on Form 8-K furnished under Item 2.02. 11

  12. Slide 12: Appendix

    Appendix Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of the Company’s most recent Current Report on Form 8-K furnished under Item 2.02. 12

  13. Slide 13: Appendix

    Appendix Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of the Company’s most recent Current Report on Form 8-K furnished under Item 2.02. 13

  14. Slide 14: AmerisourceBergen: Where knowledge, reach and partnership shape healthcare delivery

    N) AmerisourceBergen*: Where knowledge, reach and partnership shape healthcare delivery.

AmerisourceBergen — Q2 FY2017 Earnings Presentation on 6ix